Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in CanadaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of ApotexLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 14, 2026, FDA's public records list Apotex Scientific with 3 drug recalls and 1 510(k) clearance. The most recent is a drug recall dated Jan 26, 2016: Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, Manufactured….
| Jan 26, 2016 | Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, ManufactClass III · Failed Dissolution Specification: Out of specification dissolution results when testing product stability. | Drug recalls |
| Jan 26, 2016 | Duloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, ManufactClass III · Failed Dissolution Specification: Out of specification dissolution results when testing product stability. | Drug recalls |
| Jan 26, 2016 | Duloxetine Delayed-Release Capsules, USP, 30 mg, 30-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, ManufactClass III · Failed Dissolution Specification: Out of specification dissolution results when testing product stability. | Drug recalls |
| Aug 10, 1993 | ANA PROFILE IK932424 · LJM | 510(k) clearances |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
